1. A PHASE 2 CLINICAL TRIAL OF RITUXIMAB AND β‐GLUCAN PGG IN RELAPSED/REFRACTORY INDOLENT B‐CELL NON‐HODGKIN LYMPHOMA. (12th June 2019) Authors: Jacobson, C.A.; Redd, R.; Reynolds, C.; Fields, M.; Armand, P.; Fisher, D.C.; Jacobsen, E.D.; LaCasce, A.S.; Bose, N.; Ottoson, N.; Freedman, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-97 Overall survival with warfarin versus low-molecular-weight heparin in cancer-associated thrombosis. Issue 200 (April 2021) Authors: Patell, R.; Chiasakul, T.; Redd, R.; Khan, A.M.; McCarthy, E.P.; Neuberg, D.; Zwicker, J.I. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗